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Abstract
Introduction: Mycobacterium gordonae is one of the least pathogenic of the mycobacteria. This
pathogen may produce caseating or non-caseating granulomas, and skin lesions showing acute or
chronic inflammation with scattered histiocytes and giant cells have been seen. The mortality rate is
less than 0.1%. Mycobacterium gordonae may be a marker of severe immunosuppression in patients
infected with human immunodeficiency virus.
Case presentation: We report a case of Mycobacterium gordonae infection in an 86-year-old woman
and discuss the problems inherent to the identification and treatment of this emerging pathogen.
Mycobacterium gordonae strain we isolated was resistant to trimethoprim-sulfamethoxazole but
sensitive to ciprofloxacin, and long term administration (six months) induced complete healing of the
cutaneous abscesses.
Conclusion: Advanced laboratory diagnostic techniques have improved the isolation and
identification of nontuberculous mycobacteria. The diagnosis requires a high index of clinical
suspicion, as detection by conventional methods is difficult. To our knowledge, this patient is the first
documented case of cutaneous infection from this pathogen in Italy.
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Infections due to environmental mycobacteria are emer-
ging diseases not only in immunocompromised patients
but also in immunocompetent hosts.
Because of the non-specific appearance of the skin lesions,
dermatological infections from environmental mycobac-
teria are commonly misdiagnosed, making treatment of
such conditions difficult and untimely [1]. In recent years,
new species of environmental mycobacteria have emerged,
associated with skin infections. This may also be due to the
development of better identification techniques that can
distinguish species previously considered to be identical.
Mycobacterium gordonae (M. gordonae) is an acid-and
alcohol-fast bacillus belonging to the II group of
scotochromogens mycobacteria. It is ubiquitous and
commonly isolated from water (in fact, it was previously
known as the “tap water bacillus” or Mycobacterium aquae),
soil and non-pasteurized fresh milk [1]. Nosocomial
pseudo-infections due to antimicrobial and laboratory
solutions, medical instrumentation, aerosol devices and
continuous ambulatory peritoneal dialysis fluid have been
reported [2]. The contamination of instrumentation is
related to the high resistance of mycobacteria, and
especially of M. gordonae, to common chemical disinfec-
tion [3], and to the practice of rinsing medical instruments
with tap water after immersion in disinfectant
[4]. Although M.gordonae is considered one of the least
pathogenic among environmental mycobacteria, some
cases of infections have occasionally been reported in
immunocompromised and in HIV positive patients
[1]. The skin and soft tissues, cornea, synovial tissue,
meninges, prosthetic heart value, liver and peritoneum,
and lower respiratory tract are most commonly involved
[5]. The infection may also be disseminated [6]. We report
on a case of M. gordonae infection in an 86-year-old
woman and discuss the problems inherent to the
identification and treatment of this emerging pathogen.
To our knowledge, only few cases of cutaneous infection
by M. gordonae have been described in literature, mostly
occurring in immunocompetent patients [7-13].
Case presentation
An 86-year-old Caucasian Italian woman was admitted to
hospital for 6-months histories of a subcutaneous nodular
lesion on the left leg. During hospitalization, a similar
lesion appeared on the right clavicular region. Physical
examination disclosed two slightly painful, fluctuant
nodules with normal overlying skin, cool to the touch,
mobile and measuring about 7 cm and 4 cm in width,
respectively. There was no regional lymphadenopathy and
the patient was afebrile. Routine laboratory tests did not
show noteworthy alterations except for iron deficiency
anemia (HGB = 10.1 g/dl, HCT = 31.0%). Chest X-ray was
normal. Sputum and urine cultures were negative.
Immunological evaluation including peripheral blood
immunophenotyping, serum immunoglobulin levels
and HC50 resulted normal. Anti-HIV antibodies were
absent. Surgical drainage of both subcutaneous lesions
was performed, evacuating yellowish pus of low viscosity.
Direct microscopic examination of the smears from the
two lesions yielded negative results for acid-fast bacilli,
while cultures on Lowenstein-Jensen and Middlebrook
7H10 were positive 3 weeks later for mycobacteria.
Intradermal tests with PPD of Mycobacterium tuberculosis,
Mycobacterium scrofulaceum and Mycobacterium avium were
positive, whereas tests for Mycobacterium fortuitum, Myco-
bacterium marinum and Mycobacterium kansasii were nega-
tive. A biopsy specimen obtained from the lesion on the
left leg showed dermal granulomatous inflammation with
caseous necrosis. Treatment with trimethoprim/sulpha-
methoxazole was started but after two months no result
had been obtained. The patient was then re-hospitalized
and underwent surgical drainage of the abscesses and a
second culture from the smear. Contemporaneously, we
obtained biochemical identification of the mycobacterium
strain isolated from the abscesses as Mycobacterium
gordonae (whose isolation was later confirmed in the
second culture), diagnosis confirmed by microarray assay
(LCD-Array Myco) DNA based identification of Mycobac-
terium tuberculosis complex (MTUB) and other Mycobac-
teria (MOT) [13-14]. In accordance with the results of the
drug sensitivity test (Table 1), oral ciprofloxacin (1 g daily)
was given. The skin lesions showed rapid improvement
and resolved completely after 6 months of treatment.
At the time of writing, 7 months after completing the
treatment, there has been no evidence of recurrence.
Conclusions
Skin infection can follow an episode of trauma even if the
entry portal of the pathogen may appear slight or invisible.
Clinical aspects of skin lesions range from nodules to
abscesses and ulcers. The present case occurred in an
immunocompetent woman with “cold abscess” and no
obvious entry portal. The abscess, which appeared later on
the clavicular region was probably related to autoinocula-
tion, since bacteraemia seems an unlikely explanation [8].
The species isolated from both the abscesses was
undoubtedly pathogenic since all the specific criteria for
an infection due to M. gordonae were fulfilled [6].
Thecasewereportisthefirstdocumentedcaseofcutaneous
infectionfromM.gordonaeinItaly.Thediagnosisrequiresa
high index of clinical suspicion, as detection by conven-
tional methods is difficult. M. gordonae is one of the least
pathogenicofthemycobacteria.Itisusuallyacontaminant
or colonizer in patients who are not infected with HIV [1].
However, in patients who are infected with HIV and have
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+cells/µL),
M.gordonae.mayinfectthelungs,blood,bonemarrow,and
other organs[6,13]. Most cases of presumed infection have
occurred in patients with trauma, underlying immunosup-
pression, or a prosthetic device [13]. Nevertheless, it is
important to establish a timely diagnosis so that optimal
treatment can be administered [13-14]. In fact, this
organism is resistant to conventional antitubercular agents
such as isoniazid and p-aminosalicylic acid [5]. Problems
which may be caused by episodes of pseudoinfection
include delay of appropriate therapy, overgrowth of
cultures with contaminants, and risks and costs associated
with further diagnostic procedures and unnecessary ther-
apy(2,4,15).Theclinicallaboratorymustexpendtimeand
resources to identify the samples isolates, determine their
source, and notify physicians of the problem. Pseudoinfec-
tion with mycobacteria may be particularly troublesome
because of the long periods needed for growth and
identification of isolates.
M. gordonae strain we isolated was resistant to trimetho-
prim-sulfamethoxazole but sensitive to ciprofloxacin, and
long term administration (six months) induced complete
healing of the cutaneous abscesses.
Abbreviation
M. gordonae, Mycobacterium gordonae.
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Table 1. Biochemical identification and susceptibility to antibiotics of
isolated Mycobacterium gordonae
Biochemical test Result
Growth rate 37°C
Pigmentation in the dark +
Niacin −
Nitrate reduction −
Semi-quantitative catalase (>45 mm) +
68°C pH7 catalase +
Urease −
Iron uptake −
Tween 80 hydrolysis +
Mac-Conkey agar −
Susceptibility to antibiotics:
- Ciprofloxacin
- Mynocicline
- Doxycicline
- Rifampicin
- Trimethopin/Sulfa and Kanamycin
+
+
+
+
−
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